Academic Journal
DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1.
| العنوان: | DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1. |
|---|---|
| المؤلفون: | Leung, Justin W.1 (AUTHOR) leungj@uthscsa.edu, Miller, Kyle M.1,2 (AUTHOR) kyle.miller@austin.utexas.edu |
| المصدر: | Trends in Pharmacological Sciences. Nov2024, Vol. 45 Issue 11, p955-957. 3p. |
| مصطلحات موضوعية: | *HOMOLOGOUS recombination, *DNA repair, *DOUBLE-strand DNA breaks, *BRCA genes, *CANCER radiotherapy |
| مستخلص: | Breast Cancer Type 1 Susceptibility Protein (BRCA)-1 existing in several functionally distinct complexes, promotes DNA repair of DNA double-strand breaks (DSBs). A recent study by Tang and colleagues identifies the lysine methyltransferase Disruptor of Telomeric Silencing 1-Like (DOT1L) involved in modifying Receptor-Associated Protein 80 (RAP80) to promote BRCA1-A complex localization and repair functions at DNA breaks. This study illuminates a potential therapeutic target for cancer radiotherapy. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: | Academic Search Index |
| ResultId |
1 |
|---|---|
| Header |
asx Academic Search Index 180699952 1403 6 Academic Journal academicJournal 1402.71008300781 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=180699952&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
|
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1.
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Leung%2C+Justin+W%2E%22">Leung, Justin W.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> leungj@uthscsa.edu</i><br /><searchLink fieldCode="AR" term="%22Miller%2C+Kyle+M%2E%22">Miller, Kyle M.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> kyle.miller@austin.utexas.edu</i> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <searchLink fieldCode="JN" term="%22Trends+in+Pharmacological+Sciences%22">Trends in Pharmacological Sciences</searchLink>. Nov2024, Vol. 45 Issue 11, p955-957. 3p. ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => *<searchLink fieldCode="DE" term="%22HOMOLOGOUS+recombination%22">HOMOLOGOUS recombination</searchLink><br />*<searchLink fieldCode="DE" term="%22DNA+repair%22">DNA repair</searchLink><br />*<searchLink fieldCode="DE" term="%22DOUBLE-strand+DNA+breaks%22">DOUBLE-strand DNA breaks</searchLink><br />*<searchLink fieldCode="DE" term="%22BRCA+genes%22">BRCA genes</searchLink><br />*<searchLink fieldCode="DE" term="%22CANCER+radiotherapy%22">CANCER radiotherapy</searchLink> ) Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => Breast Cancer Type 1 Susceptibility Protein (BRCA)-1 existing in several functionally distinct complexes, promotes DNA repair of DNA double-strand breaks (DSBs). A recent study by Tang and colleagues identifies the lysine methyltransferase Disruptor of Telomeric Silencing 1-Like (DOT1L) involved in modifying Receptor-Associated Protein 80 (RAP80) to promote BRCA1-A complex localization and repair functions at DNA breaks. This study illuminates a potential therapeutic target for cancer radiotherapy. [ABSTRACT FROM AUTHOR] ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1016/j.tips.2024.09.008
)
)
[Languages] => Array
(
[0] => Array
(
[Code] => eng
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 3
[StartPage] => 955
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => HOMOLOGOUS recombination
[Type] => general
)
[1] => Array
(
[SubjectFull] => DNA repair
[Type] => general
)
[2] => Array
(
[SubjectFull] => DOUBLE-strand DNA breaks
[Type] => general
)
[3] => Array
(
[SubjectFull] => BRCA genes
[Type] => general
)
[4] => Array
(
[SubjectFull] => CANCER radiotherapy
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1.
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Leung, Justin W.
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Miller, Kyle M.
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 11
[Text] => Nov2024
[Type] => published
[Y] => 2024
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 01656147
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 45
)
[1] => Array
(
[Type] => issue
[Value] => 11
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Trends in Pharmacological Sciences
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |